Autoimmune inner ear disease: Clinical and laboratory findings and treatment outcome

Journal of Otolaryngology - Head and Neck Surgery

Volumn 37, Issue 4, 2008, Pages 591-596

  Dayal, Vijay S ^a,b   Ellman, Michael ^a   Sweiss, Nadera ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC 1035 ^*  (United States)

Author keywords

Auditory; Autoimmune inner ear disease; Serologic; Vestibular

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; ETANERCEPT; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; STEROID;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE INNER EAR DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEMOGRAPHY; DISEASE COURSE; DRUG RESPONSE; FEMALE; HEARING LOSS; HUMAN; INNER EAR DISEASE; LABORATORY TEST; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SERODIAGNOSIS; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TERTIARY HEALTH CARE; TREATMENT OUTCOME; VESTIBULAR TEST;

ADULT; AUTOIMMUNE DISEASES; DISEASE PROGRESSION; FEMALE; HEARING DISORDERS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 64549093785     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2008.0113     Document Type: Article

References (33)

1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
2. Lehnhardt E. Sudden hearing disorders occurring simultaneously or successively on both sides. Z Laryngol Rhinol Otol 1958;37:1-16.
3. Schiff N, Brown D. Hormones in sudden deafness. Laryngoscope 1974;84:1959.
4. Cogan DG. Syndrome of non-syphilitic interstitial keratits and vestibular auditory symptoms. Arch Ophthalmol 1945;33:144.
5. Harris JP. Autoimmune diseases affecting the inner ear. Adv Otolaryngol Head Neck Surg 1993;7:59-77.
6. Stone JH, Francis HW. Immune-mediated inner ear disease. Curr Opin Rheumatol 2000;12:32-40.
7. Lorenz RR, Solares CA, Williams P, et al. Interferon gamma production of inner ear antigen by T-cells from patients with autoimmune sensorineural hearing loss. J Neuroimmunol 2002; 130:173-8.
8. Garcia Callejo FJ, Marco Algara J, Martinez Beneyto MP, et al. Autoimmune identification of sudden hearing loss. Acta Otolaryngol (Stockh) 2003;123:168-71.
9. Deutschlander AF, Glaser MF, Strupp M, et al. Immuno-suppressive treatment in bilateral vestibulopathy with inner antibodies. Acta Otolaryngol (Stockh) 2005;125:848-51.
10. Billings PB, Keithley EM, Harris JP. Evidence linking the sixty-eight kD antigens identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol 1995;104:181-8.
11. Moscicki RA, San Martin JE, Quintero CH, et al. Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment. JAMA 1994;272:611-6.
12. Hughes GB, Barna BP, Kinney SE, et al. Predictive value of laboratory test in autoimmune inner ear disease: preliminary report. Laryngoscope 1986;96:502-5.
13. Harris JP, Sharp PA. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990; 100:516-24.
14. Yeom K, Gray J, Nair TS, et al. Antibodies to HSP-70 in normal donors and autoimmune hearing loss patients. Laryngoscope 2003; 113:1770-6.
15. Garcia Berrocal JR, Ramirez-Camacho R, Vargas JA, et al. Does the serological testing really play a role in the diagnosis of autoimmune-mediated inner ear disease? Acta Otolaryngol (Stockh) 2002;122:243-8.
16. Hirose H, Weiner MH, Duckert LG. Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 1999;109:1749-54.
17. Broughton SS, Meyerhoff WE, Cohen SB. Immune mediated inner ear disease; 10 year experience. Semin Arthritis Rheum 2004;34: 544-8.
18. Rahman M, Poe D, Choi H. Autoimmune vestibular cochlear disorders. Curr Opin Rheumatol 2001;13:184-9.
19. Aqrup C, Luxon LM. Immune mediated inner ear disorders in neuron-otology. Curr Opin Neurol 2006;19:26-32.
20. Committee on Hearing and Equilibrium, Otolaryngol Head Neck Surg 1995;113:179-80.
21. Leliever WC, Barber HO. Recurrent vestibulopathy. Laryngoscope 1981;91:1-6.
22. Schuknecht HF, Nadol JB. Temporal bone pathology in a case of Cogan's syndrome. Laryngoscope 1994;104:1135-42.
23. Hoffman KK, Silverstein H. Inner ear prefusion: indications and applications. Curr Opin Otolaryngol Head Neck Surg 2003;11:334-9.
24. Yang GS, Song HT, Keithley EM, Harris JP. Intratympanic immuno-suppressives for prevention of immune-mediated sensor-ineural hearing loss. Am J Otol 2000;21:499-504.
25. Haynes DS, O'Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3-15.
26. Loveman DM, de Comarmond C, Cepero R, et al. Semin Arthritis Rheum, 2004;34:538-43.
27. Sismanis A, Thompson T, Willis HE. Methotrexate therapy for autoimmune hearing loss: a preliminary report. Laryngoscope 1994;104:932-4.
28. Harris JP, Weisman MH, Derebery JM, et al. Treatment of corticosteroids-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 2003;209: 1875-83.
29. Street I, Jobanputra P, Proops DW. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss. J Laryngol Otol 2006;120:1064-6.
30. Cohen S, Shoup A, Weisman MH, et al. Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study. Otol Neurotol 2005;26:903-7.
31. Van Wijk F, Staecker H, Keithley E, Lefebvre PP. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurotol 2006;11:357-65.
32. Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease. Acta Otolaryngol (Stockh) 2006;126:1012-21.
33. Mouadeb DA, Ruckenstein MJ. Antiphospholipid inner ear syndrome. Laryngoscope 2005;115:879-83.